PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.86%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
19.55%
Similar cost growth to CRWV's 19.16%. Walter Schloss would investigate if industry cost pressures are temporary.
-1.35%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
-3.15%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
20.58%
R&D change of 20.58% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.59%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-13.71%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-30.51%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
30.43%
Similar EBITDA growth to CRWV's 33.05%. Walter Schloss would investigate industry trends.
11.68%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
43.55%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
40.93%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
11.72%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
36.07%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
33.58%
Pre-tax margin growth 1.25-1.5x CRWV's 26.86%. Bruce Berkowitz would examine sustainability.
36.05%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
36.07%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
33.59%
Net margin growth 1.25-1.5x CRWV's 25.27%. Bruce Berkowitz would examine sustainability.
71.43%
EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
71.43%
Diluted EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
0.74%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
1.37%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.